[
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
    "summary": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=309956ba46adb2994f06e7e82a066a6c4996e92558b5573b405583e9fb9a2fa7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761064380,
      "headline": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
      "id": 137226251,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=309956ba46adb2994f06e7e82a066a6c4996e92558b5573b405583e9fb9a2fa7"
    }
  },
  {
    "ts": null,
    "headline": "Functional Foods Forecast and Company Analysis Report 2025: A $678.32 Billion Market by 2033 Featuring Abbott, Amway, BASF, Cargill, Clif Ba, Danone, General Mills, Kellogg, Kerry, Nestle",
    "summary": "The Global Functional Foods Market is set to expand at a CAGR of 7.92% from 2025 to 2033, reaching $678.32 billion by 2033, up from $341.6 billion in 2024. The surge is driven by increasing health awareness, demand for fortified foods, and an emphasis on preventive healthcare. Functional foods, enhanced with vitamins, minerals, and probiotics, are gaining traction among health-conscious consumers aiming to prevent chronic diseases. Key markets include the U.S., Germany, and India, with bakery an",
    "url": "https://finnhub.io/api/news?id=d9b2f18b1b3f1c1807e75667207a996a1e4836927674d3aad71c20f0d6edeec5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761051480,
      "headline": "Functional Foods Forecast and Company Analysis Report 2025: A $678.32 Billion Market by 2033 Featuring Abbott, Amway, BASF, Cargill, Clif Ba, Danone, General Mills, Kellogg, Kerry, Nestle",
      "id": 137178100,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Global Functional Foods Market is set to expand at a CAGR of 7.92% from 2025 to 2033, reaching $678.32 billion by 2033, up from $341.6 billion in 2024. The surge is driven by increasing health awareness, demand for fortified foods, and an emphasis on preventive healthcare. Functional foods, enhanced with vitamins, minerals, and probiotics, are gaining traction among health-conscious consumers aiming to prevent chronic diseases. Key markets include the U.S., Germany, and India, with bakery an",
      "url": "https://finnhub.io/api/news?id=d9b2f18b1b3f1c1807e75667207a996a1e4836927674d3aad71c20f0d6edeec5"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience",
    "summary": "Abbott Laboratories (NYSE:ABT) ranks among the best medical device stocks to invest in. Benchmark began coverage of Abbott Laboratories (NYSE:ABT) on October 10 with a $145 price target and a Buy rating, describing the company as a reliable performer in a dynamic global environment. The firm claims that Abbott’s business strategy is unique in that […]",
    "url": "https://finnhub.io/api/news?id=2ff5914ff0e71d63710a024044851aacb23d254e62d5d6bdd4863edd91fdc1cb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761042798,
      "headline": "Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience",
      "id": 137178103,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) ranks among the best medical device stocks to invest in. Benchmark began coverage of Abbott Laboratories (NYSE:ABT) on October 10 with a $145 price target and a Buy rating, describing the company as a reliable performer in a dynamic global environment. The firm claims that Abbott’s business strategy is unique in that […]",
      "url": "https://finnhub.io/api/news?id=2ff5914ff0e71d63710a024044851aacb23d254e62d5d6bdd4863edd91fdc1cb"
    }
  },
  {
    "ts": null,
    "headline": "Home Healthcare Market Research Report 2025-2030: Leading Companies are Innovating and Introducing New Home Healthcare Products to Gain a Competitive Advantage",
    "summary": "The global home healthcare market is projected to reach USD 473.8 billion by 2030, up from USD 309.9 billion in 2025, growing at a CAGR of 8.9%. This expansion is driven by rising lifestyle-related disorders such as high blood pressure, obesity, and cardiac conditions. Leading companies are innovating and introducing new home healthcare products. The therapeutic products segment holds the largest market share, fueled by a growing prevalence of chronic health conditions. Skilled nursing services",
    "url": "https://finnhub.io/api/news?id=e2844ad66686cf216a6d30da1315b952146cec0e30a6e0510a0dcd8a2b66ebbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761038520,
      "headline": "Home Healthcare Market Research Report 2025-2030: Leading Companies are Innovating and Introducing New Home Healthcare Products to Gain a Competitive Advantage",
      "id": 137174740,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The global home healthcare market is projected to reach USD 473.8 billion by 2030, up from USD 309.9 billion in 2025, growing at a CAGR of 8.9%. This expansion is driven by rising lifestyle-related disorders such as high blood pressure, obesity, and cardiac conditions. Leading companies are innovating and introducing new home healthcare products. The therapeutic products segment holds the largest market share, fueled by a growing prevalence of chronic health conditions. Skilled nursing services",
      "url": "https://finnhub.io/api/news?id=e2844ad66686cf216a6d30da1315b952146cec0e30a6e0510a0dcd8a2b66ebbf"
    }
  },
  {
    "ts": null,
    "headline": "Did Mixed Segment Results and Narrowed Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative?",
    "summary": "In October 2025, Abbott Laboratories reported third-quarter results showing US$11.37 billion in sales and reaffirmed its 2025 earnings guidance, narrowing expected full-year adjusted diluted EPS to US$5.12–US$5.18, while guiding for organic sales growth of 7.5%–8.0% excluding COVID-19 testing. Despite strong medical device sales, the company faced mixed results due to challenges in its diagnostics and nutrition segments, prompting investors to focus closely on its revised annual outlook and...",
    "url": "https://finnhub.io/api/news?id=cff5b4871bc6bafc125eb3fd4fdcb5a79ce14a601c7973f815b07b0dc6bbbbb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761034252,
      "headline": "Did Mixed Segment Results and Narrowed Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative?",
      "id": 137174214,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "In October 2025, Abbott Laboratories reported third-quarter results showing US$11.37 billion in sales and reaffirmed its 2025 earnings guidance, narrowing expected full-year adjusted diluted EPS to US$5.12–US$5.18, while guiding for organic sales growth of 7.5%–8.0% excluding COVID-19 testing. Despite strong medical device sales, the company faced mixed results due to challenges in its diagnostics and nutrition segments, prompting investors to focus closely on its revised annual outlook and...",
      "url": "https://finnhub.io/api/news?id=cff5b4871bc6bafc125eb3fd4fdcb5a79ce14a601c7973f815b07b0dc6bbbbb2"
    }
  },
  {
    "ts": null,
    "headline": "Abbott and BIG CARiNG Group Launch Nationwide Influenza Awareness Program to Strengthen Public Health Response Through Early Intervention",
    "summary": "Abbott, a global healthcare leader, and BIG CARiNG Group (BCG), one of Malaysia's largest retail pharmacies, announced a strategic three-year collaboration to promote influenza awareness across Malaysia. The Influenza Awareness Program, running from 2025 to 2027, is designed to elevate public understanding of influenza and encourage proactive health management.",
    "url": "https://finnhub.io/api/news?id=ebc16e10229a9feba5a2096ee7659d774ebcbaaf4b887976a2ec7d8ebc0a7375",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761023520,
      "headline": "Abbott and BIG CARiNG Group Launch Nationwide Influenza Awareness Program to Strengthen Public Health Response Through Early Intervention",
      "id": 137174215,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott, a global healthcare leader, and BIG CARiNG Group (BCG), one of Malaysia's largest retail pharmacies, announced a strategic three-year collaboration to promote influenza awareness across Malaysia. The Influenza Awareness Program, running from 2025 to 2027, is designed to elevate public understanding of influenza and encourage proactive health management.",
      "url": "https://finnhub.io/api/news?id=ebc16e10229a9feba5a2096ee7659d774ebcbaaf4b887976a2ec7d8ebc0a7375"
    }
  }
]